Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells

Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells

Autologous T cells engineered with T receptor genes (TCR) are being studied to treat cancers. We have recently identified a panel of mouse TCRs specific for the HLA-A0201/alpha fetoprotein epitope (AFP158) complex and have shown that human T cells engineered with these TCR genes (TCR-Ts) can eradica...

ver descrição completa

Detalhes bibliográficos
Principais autores: Lun Cai, Leidy D. Caraballo Galva, Yibing Peng, Xiaobing Luo, Wei Zhu, Yihong Yao, Yun Ji, Yukai He
Formato: Artigo
Idioma:English
Publicado em: Frontiers Media S.A. 2020-04-01
coleção:Frontiers in Immunology
Assuntos:
T cell receptors
T cell engineering
alpha fetoprotein
hepatocellular carcinoma
TCR cross-reactivity
off-target toxicity
Acesso em linha:https://www.frontiersin.org/article/10.3389/fimmu.2020.00607/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.00607/full

Registros relacionados